Annual EBIT
-$892.85 M
+$1.23 B+57.91%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual earnings before interest & taxes is -$892.85 million, with the most recent change of +$1.23 billion (+57.91%) on December 31, 2023.
- During the last 3 years, DNA annual EBIT has fallen by -$770.40 million (-629.16%).
- DNA annual EBIT is now -660.43% below its all-time high of -$117.41 million, reached on December 31, 2019.
Performance
DNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$52.26 M
+$105.77 M+66.93%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly earnings before interest & taxes is -$52.26 million, with the most recent change of +$105.77 million (+66.93%) on September 30, 2024.
- Over the past year, DNA quarterly EBIT has increased by +$250.51 million (+82.74%).
- DNA quarterly EBIT is now -104.70% below its all-time high of -$25.53 million, reached on September 30, 2020.
Performance
DNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$691.05 M
+$137.93 M+16.64%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM earnings before interest & taxes is -$691.05 million, with the most recent change of +$137.93 million (+16.64%) on September 30, 2024.
- Over the past year, DNA TTM EBIT has increased by +$201.80 million (+22.60%).
- DNA TTM EBIT is now -2607.01% below its all-time high of -$25.53 million, reached on September 30, 2020.
Performance
DNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.9% | +82.7% | +22.6% |
| 3 y3 years | -629.2% | +82.7% | +22.6% |
| 5 y5 years | -660.4% | -104.7% | -2607.0% |
DNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.9% | at high | +96.9% | at high | +81.2% |
| 5 y | 5-year | -660.4% | +57.9% | -104.7% | +96.9% | -2607.0% | +81.2% |
| alltime | all time | -660.4% | +57.9% | -104.7% | +96.9% | -2607.0% | +81.2% |
Ginkgo Bioworks Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$52.26 M(-66.9%) | -$691.05 M(-16.6%) |
| Jun 2024 | - | -$158.02 M(-11.2%) | -$828.97 M(-3.1%) |
| Mar 2024 | - | -$178.00 M(-41.2%) | -$855.10 M(-4.2%) |
| Dec 2023 | -$892.85 M(-57.9%) | -$302.77 M(+59.2%) | -$892.85 M(+21.8%) |
| Sep 2023 | - | -$190.18 M(+3.3%) | -$733.28 M(-38.8%) |
| Jun 2023 | - | -$184.15 M(-14.6%) | -$1.20 B(-27.9%) |
| Mar 2023 | - | -$215.75 M(+50.7%) | -$1.66 B(-21.7%) |
| Dec 2022 | -$2.12 B | -$143.21 M(-78.1%) | -$2.12 B(-42.2%) |
| Sep 2022 | - | -$654.94 M(+1.1%) | -$3.67 B(+20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$647.78 M(-4.1%) | -$3.04 B(+24.0%) |
| Mar 2022 | - | -$675.37 M(-60.1%) | -$2.45 B(+32.4%) |
| Dec 2021 | -$1.84 B(+1399.2%) | -$1.69 B(+6243.8%) | -$1.85 B(+795.7%) |
| Sep 2021 | - | -$26.67 M(-55.5%) | -$206.88 M(+0.6%) |
| Jun 2021 | - | -$59.95 M(-19.5%) | -$205.74 M(+41.1%) |
| Mar 2021 | - | -$74.46 M(+62.6%) | -$145.79 M(+104.4%) |
| Dec 2020 | -$122.45 M(+4.3%) | -$45.80 M(+79.4%) | -$71.33 M(+179.4%) |
| Sep 2020 | - | -$25.53 M | -$25.53 M |
| Dec 2019 | -$117.41 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual EBIT year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly EBIT year-on-year change?
- What is Ginkgo Bioworks Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM EBIT year-on-year change?
What is Ginkgo Bioworks Holdings annual earnings before interest & taxes?
The current annual EBIT of DNA is -$892.85 M
What is the all time high annual EBIT for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual earnings before interest & taxes is -$117.41 M
What is Ginkgo Bioworks Holdings annual EBIT year-on-year change?
Over the past year, DNA annual earnings before interest & taxes has changed by +$1.23 B (+57.91%)
What is Ginkgo Bioworks Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of DNA is -$52.26 M
What is the all time high quarterly EBIT for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly earnings before interest & taxes is -$25.53 M
What is Ginkgo Bioworks Holdings quarterly EBIT year-on-year change?
Over the past year, DNA quarterly earnings before interest & taxes has changed by +$250.51 M (+82.74%)
What is Ginkgo Bioworks Holdings TTM earnings before interest & taxes?
The current TTM EBIT of DNA is -$691.05 M
What is the all time high TTM EBIT for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM earnings before interest & taxes is -$25.53 M
What is Ginkgo Bioworks Holdings TTM EBIT year-on-year change?
Over the past year, DNA TTM earnings before interest & taxes has changed by +$201.80 M (+22.60%)